bendroflumethiazide has been researched along with pd 123319 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, Q; Hussain, T | 1 |
1 other study(ies) available for bendroflumethiazide and pd 123319
Article | Year |
---|---|
AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats.
Topics: Amiloride; Angiotensin II Type 1 Receptor Blockers; Animals; Bendroflumethiazide; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Imidazoles; Male; Natriuresis; Natriuretic Agents; Obesity; Pyridines; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Sodium; Sodium Chloride Symporter Inhibitors; Sodium Chloride Symporters; Sulfonamides; Thiophenes; Urination | 2012 |